-
The glycosyltransferase GnT-III activates Notch signaling and drives stem cell expansion to promote the growth and invasion
of ovarian cancer
Heba Allam, Blake P. Johnson, Mao Zhang, Zhongpeng Lu, Martin J. Cannon, and Karen L. Abbott
Journal of Biological Chemistry
(2017)
292 :16351
-
Correlations of Differentially Expressed Gap Junction Connexins Cx26, Cx30, Cx32, Cx43 and Cx46 with Breast Cancer Progression
and Prognosis
Ivett Teleki, Attila Marcell Szasz, Mate Elod Maros, Balazs Gyorffy, Janina Kulka, Nora Meggyeshazi, Gergo Kiszner, Peter
Balla, Aliz Samu, Tibor Krenacs, and Eliana Scemes
PLoS ONE
(2014)
9 :e112541
-
FAK activity protects nucleostemin in facilitating breast cancer spheroid and tumor growth
Isabelle Tancioni, Nichol LG Miller, Sean Uryu, Christine Lawson, Christine Jean, Xiao Lei Chen, Elizabeth G Kleinschmidt,
and David D Schlaepfer
Breast Cancer Research
(2015)
17 :
-
Mining expression and prognosis of topoisomerase isoforms in non-small-cell lung cancer by using Oncomine and Kaplan–Meier
plotter
Guo-Xin Hou, Panpan Liu, Jing Yang, Shijun Wen, and Renato Franco
PLOS ONE
(2017)
12 :e0174515
-
Prognostic values of four Notch receptor mRNA expression in gastric cancer
Xiaoyu Wu, Wentao Liu, Ding Tang, Haijuan Xiao, Zhenfeng Wu, Che Chen, Xuequan Yao, Fukun Liu, and Gang Li
Scientific Reports
(2016)
6 :
-
Tribbles 2 mediates cisplatin sensitivity and DNA damage response in epithelial ovarian cancer
Daniel Kritsch, Franziska Hoffmann, Daniel Steinbach, Lars Jansen, Stella Mary Photini, Mieczyslaw Gajda, Alexander S. Mosig,
Jürgen Sonnemann, Sven Peters, Margarita Melnikova, Jürgen Thomale, Matthias Dürst, Ingo B. Runnebaum, and Norman Häfner
International Journal of Cancer
(2017)
141 :1600
-
The human organic cation transporter OCT1 mediates high affinity uptake of the anticancer drug daunorubicin
Emil Andreev, Nicolas Brosseau, Euridice Carmona, Anne-Marie Mes-Masson, and Dindial Ramotar
Scientific Reports
(2016)
6 :
-
Deletion at 6q24.2-26 predicts longer survival of high-grade serous epithelial ovarian cancer patients
Marta M. Kamieniak, Daniel Rico, Roger L. Milne, Ivan Muñoz-Repeto, Kristina Ibáñez, Miguel A. Grillo, Samuel Domingo, Salud
Borrego, Alicia Cazorla, José M. García-Bueno, Susana Hernando, Jesús García-Donas, Elena Hernández-Agudo, Teresa Ramón y
Cajal, Luis Robles-Díaz, Ivan Márquez-Rodas, Maite Cusidó, Raquel Sáez, Carmen Lacambra-Calvet, Ana Osorio, Miguel Urioste,
Juan C. Cigudosa, Luis Paz-Ares, José Palacios, Javier Benítez, and María J. García
Molecular Oncology
(2015)
9 :422
-
CD55 regulates self-renewal and cisplatin resistance in endometrioid tumors
Caner Saygin, Andrew Wiechert, Vinay S. Rao, Ravi Alluri, Elizabeth Connor, Praveena S. Thiagarajan, James S. Hale, Yan Li,
Anastasia Chumakova, Awad Jarrar, Yvonne Parker, Daniel J. Lindner, Anil Belur Nagaraj, J. Julie Kim, Analisa DiFeo, Fadi
W. Abdul-Karim, Chad Michener, Peter G. Rose, Robert DeBernardo, Haider Mahdi, Keith R. McCrae, Feng Lin, Justin D. Lathia,
and Ofer Reizes
The Journal of Experimental Medicine
(2017)
214 :2715
-
The acetyltransferase Tip60 contributes to mammary tumorigenesis by modulating DNA repair
C Bassi, Y-T Li, K Khu, F Mateo, P S Baniasadi, A Elia, J Mason, V Stambolic, M A Pujana, T W Mak, and C Gorrini
Cell Death and Differentiation
(2016)
23 :1198
-
Vangl1 and Vangl2: planar cell polarity components with a developing role in cancer
J. Hatakeyama, J. H. Wald, I. Printsev, H.-Y. H. Ho, and K. L. Carraway
Endocrine Related Cancer
(2014)
21 :R345
-
High expression of crystallin αB represents an independent molecular marker for unfavourable ovarian cancer patient outcome
and impairs TRAIL- and cisplatin-induced apoptosis in human ovarian cancer cells
Juliane Volkmann, Ute Reuning, Martina Rudelius, Norman Häfner, Tibor Schuster, Aaron Becker v. Rose, Joerg Weimer, Felix
Hilpert, Marion Kiechle, Matthias Dürst, Norbert Arnold, Barbara Schmalfeldt, Alfons Meindl, and Juliane Ramser
International Journal of Cancer
(2013)
132 :2820
-
Proteasome ubiquitin receptor PSMD4
is an amplification target in breast cancer and may predict sensitivity to PARPi
Marlena S. Fejzo, Lee Anderson, Hsiao-Wang Chen, Enrique Guandique, Ondrej Kalous, Dylan Conklin, and Dennis J. Slamon
Genes, Chromosomes and Cancer
(2017)
56 :589
-
Targeting Vascular Pericytes in Hypoxic Tumors Increases Lung Metastasis via Angiopoietin-2
Doruk Keskin, Jiha Kim, Vesselina G. Cooke, Chia-Chin Wu, Hikaru Sugimoto, Chenghua Gu, Michele De Palma, Raghu Kalluri, and
Valerie S. LeBleu
Cell Reports
(2015)
10 :1066
-
WWOX at the crossroads of cancer, metabolic syndrome related traits and CNS pathologies
C. Marcelo Aldaz, Brent W. Ferguson, and Martin C. Abba
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
(2014)
1846 :188
-
Suppression of the grainyhead transcription factor 2 gene (GRHL2) inhibits the proliferation, migration, invasion and mediates
cell cycle arrest of ovarian cancer cells
Adnen Faddaoui, Razan Sheta, Magdalena Bachvarova, Marie Plante, Jean Gregoire, Marie-Claude Renaud, Alexandra Sebastianelli,
Stephane Gobeil, Chantale Morin, Karim Ghani, and Dimcho Bachvarov
Cell Cycle
(2017)
16 :693
-
The MicroRNA-23b/27b/24 Cluster Promotes Breast Cancer Lung Metastasis by Targeting Metastasis-suppressive Gene Prosaposin
Brian Ell, Qiong Qiu, Yong Wei, Laura Mercatali, Toni Ibrahim, Dino Amadori, and Yibin Kang
Journal of Biological Chemistry
(2014)
289 :21888
-
Elafin drives poor outcome in high-grade serous ovarian cancers and basal-like breast tumors
S I Labidi-Galy, A Clauss, V Ng, S Duraisamy, K M Elias, H-Y Piao, E Bilal, R A Davidowitz, Y Lu, G Badalian-Very, B Györffy,
U-B Kang, S Ficarro, S Ganesan, G B Mills, J A Marto, and R Drapkin
Oncogene
(2015)
34 :373
-
Tumour cell-derived Wnt7a recruits and activates fibroblasts to promote tumour aggressiveness
Alexandra Avgustinova, Marjan Iravani, David Robertson, Antony Fearns, Qiong Gao, Pamela Klingbeil, Andrew M. Hanby, Valerie
Speirs, Erik Sahai, Fernando Calvo, and Clare M. Isacke
Nature Communications
(2016)
7 :10305
-
Elevated APOBEC3B Correlates with Poor Outcomes for Estrogen-Receptor-Positive Breast Cancers
Anieta M. Sieuwerts, Scooter Willis, Michael B. Burns, Maxime P. Look, Marion E. Meijer-Van Gelder, Andreas Schlicker, Marinus
R. Heideman, Heinz Jacobs, Lodewyk Wessels, Brian Leyland-Jones, Kathryn P. Gray, John A. Foekens, Reuben S. Harris, and John
W. M. Martens
Hormones and Cancer
(2014)
5 :405
-
Downregulation of the cancer susceptibility protein WRAP53β in epithelial ovarian cancer leads to defective DNA repair and
poor clinical outcome
E Hedström, C Pederiva, J Farnebo, B Nodin, K Jirström, D J Brennan, and M Farnebo
Cell Death and Disease
(2015)
6 :e1892
-
Wilms tumor protein 1 (WT1) — Not only a diagnostic but also a prognostic marker in high-grade serous ovarian carcinoma
Eliane Tabea Taube, Carsten Denkert, Jalid Sehouli, Catarina Alisa Kunze, Manfred Dietel, Ioana Braicu, Anne Letsch, and Silvia
Darb-Esfahani
Gynecologic Oncology
(2016)
140 :494
-
FGFR2 regulates Mre11 expression and double-strand break repair via the MEK-ERK-POU1F1 pathway in breast tumorigenesis
Y.-L. Huang, W.-C. Chou, C.-N. Hsiung, L.-Y. Hu, H.-W. Chu, and C.-Y. Shen
Human Molecular Genetics
(2015)
24 :3506
-
Inhibition of focal adhesion kinase (FAK) activity prevents anchorage-independent ovarian carcinoma cell growth and tumor
progression
Kristy K. Ward, Isabelle Tancioni, Christine Lawson, Nichol L. G. Miller, Christine Jean, Xiao Lei Chen, Sean Uryu, Josephine
Kim, David Tarin, Dwayne G. Stupack, Steven C. Plaxe, and David D. Schlaepfer
Clinical & Experimental Metastasis
(2013)
30 :579
-
HOXA5 indicates poor prognosis and suppresses cell proliferation by regulating p21 expression in non small cell lung cancer
Mei-ling Zhang, Feng-qi Nie, Ming Sun, Rui Xia, Min Xie, Kai-hua Lu, and Wei Li
Tumor Biology
(2015)
36 :3521
-
miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients
András Lánczky, Ádám Nagy, Giulia Bottai, Gyöngyi Munkácsy, András Szabó, Libero Santarpia, and Balázs Győrffy
Breast Cancer Research and Treatment
(2016)
160 :439
-
Secreted CLIC3 drives cancer progression through its glutathione-dependent oxidoreductase activity
Juan R. Hernandez-Fernaud, Elena Ruengeler, Andrea Casazza, Lisa J. Neilson, Ellie Pulleine, Alice Santi, Shehab Ismail, Sergio
Lilla, Sandeep Dhayade, Iain R. MacPherson, Iain McNeish, Darren Ennis, Hala Ali, Fernanda G. Kugeratski, Heba Al Khamici,
Maartje van den Biggelaar, Peter V.E. van den Berghe, Catherine Cloix, Laura McDonald, David Millan, Aoisha Hoyle, Anna Kuchnio,
Peter Carmeliet, Stella M. Valenzuela, Karen Blyth, Huabing Yin, Massimiliano Mazzone, Jim C. Norman, and Sara Zanivan
Nature Communications
(2017)
8 :14206
-
Type I IFN induces protein ISGylation to enhance cytokine expression and augments colonic inflammation
Jun-Bao Fan, Sayuri Miyauchi-Ishida, Kei-ichiro Arimoto, Dan Liu, Ming Yan, Chang-Wei Liu, Balázs Győrffy, and Dong-Er Zhang
Proceedings of the National Academy of Sciences
(2015)
112 :14313
-
Fructose-1,6-bisphosphatase is a novel regulator of Wnt/β-Catenin pathway in breast cancer
Kaichun Li, Mingzhen Ying, Dan Feng, Jie Du, Shiyu Chen, Bing Dan, Cuihua Wang, and Yajie Wang
Biomedicine & Pharmacotherapy
(2016)
84 :1144
-
Decreased expression of ALDH5A1 predicts prognosis in patients with ovarian cancer
Xun Tian, Yingyan Han, Lan Yu, Bo Luo, Zheng Hu, Xiong Li, Zongyuan Yang, Xin Wang, Wanqiu Huang, Hui Wang, Qinghua Zhang,
and Ding Ma
Cancer Biology & Therapy
(2017)
18 :245
-
Specific Mesothelial Signature Marks the Heterogeneity of Mesenchymal Stem Cells From High-Grade Serous Ovarian Cancer
Roberto Verardo, Silvano Piazza, Enio Klaric, Yari Ciani, Giulio Bussadori, Stefania Marzinotto, Laura Mariuzzi, Daniela Cesselli,
Antonio P. Beltrami, Miguel Mano, Masayoshi Itoh, Hideya Kawaji, Timo Lassmann, Piero Carninci, Yoshihide Hayashizaki, Alistair
R. R. Forrest, Carlo A. Beltrami, and Claudio Schneider
STEM CELLS
(2014)
32 :2998
-
Efficient Regularized Regression withL0Penalty for Variable Selection and Network Construction
Zhenqiu Liu and Gang Li
Computational and Mathematical Methods in Medicine
(2016)
2016 :1
-
MEK1 is associated with carboplatin resistance and is a prognostic biomarker in epithelial ovarian cancer
Zsófia Pénzváltó, András Lánczky, Julianna Lénárt, Nóra Meggyesházi, Tibor Krenács, Norbert Szoboszlai, Carsten Denkert, Imre
Pete, and Balázs Győrffy
BMC Cancer
(2014)
14 :
-
Stomatin-like protein 2 is overexpressed in epithelial ovarian cancer and predicts poor patient survival
Fei Sun, Wen Ding, Jie-Hua He, Xiao-Jing Wang, Ze-Biao Ma, and Yan-Fang Li
BMC Cancer
(2015)
15 :
-
PROGgene: gene expression based survival analysis web application for multiple cancers
Chirayu Goswami and Harikrishna Nakshatri
Journal of Clinical Bioinformatics
(2013)
3 :22
-
Cancer-testis antigen cyclin A1 is broadly expressed in ovarian cancer and is associated with prolonged time to tumor progression
after platinum-based therapy
Ruza Arsenic, Elena Ilona Braicu, Anne Letsch, Manfred Dietel, Jalid Sehouli, Ulrich Keilholz, and Sebastian Ochsenreither
BMC Cancer
(2015)
15 :
-
C1GALT1 Seems to Promote In Vitro Disease Progression in Ovarian Cancer
Chih-Hsing Chou, Miao-Juei Huang, Ying-Yu Liao, Chi-Hau Chen, and Min-Chuan Huang
International Journal of Gynecological Cancer
(2017)
27 :863
-
Peroxiredoxin 1 interacts with and blocks the redox factor APE1 from activating interleukin-8 expression
Hassan Nassour, Zhiqiang Wang, Amine Saad, Arturo Papaluca, Nicolas Brosseau, El Bachir Affar, Moulay A. Alaoui-Jamali, and
Dindial Ramotar
Scientific Reports
(2016)
6 :
-
Cross-validation of genes potentially associated with overall survival and drug resistance in ovarian cancer
Yutao Gao, Xia Liu, Ting Li, Luwei Wei, Antai Yang, Yi Lu, Jian Zhang, Li Li, Sumei Wang, and Fuqiang Yin
Oncology Reports
(2017)
37 :3084
-
POSTN/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian cancer
Beth Y. Karlan, Judy Dering, Christine Walsh, Sandra Orsulic, Jenny Lester, Lee A. Anderson, Charles L. Ginther, Marlena Fejzo,
and Dennis Slamon
Gynecologic Oncology
(2014)
132 :334
-
Interferon regulatory factor 1 is an independent predictor of platinum resistance and survival in high-grade serous ovarian
carcinoma
Samantha Cohen, Rebecca Mosig, Erin Moshier, Elena Pereira, Jamal Rahaman, Monica Prasad-Hayes, Richard Halpert, Jean-Noel
Billaud, Peter Dottino, and John A. Martignetti
Gynecologic Oncology
(2014)
134 :591
-
A transcriptome-based global map of signaling pathways in the ovarian cancer microenvironment associated with clinical outcome
Silke Reinartz, Florian Finkernagel, Till Adhikary, Verena Rohnalter, Tim Schumann, Yvonne Schober, W. Andreas Nockher, Andrea
Nist, Thorsten Stiewe, Julia M. Jansen, Uwe Wagner, Sabine Müller-Brüsselbach, and Rolf Müller
Genome Biology
(2016)
17 :
-
OvMark: a user-friendly system for the identification of prognostic biomarkers in publically available ovarian cancer gene
expression datasets
Stephen F Madden, Colin Clarke, Britta Stordal, Mark S Carey, Russell Broaddus, William M Gallagher, John Crown, Gordon B
Mills, and Bryan T Hennessy
Molecular Cancer
(2014)
13 :241
-
Nicotine-Mediated Regulation of Nicotinic Acetylcholine Receptors in Non-Small Cell Lung Adenocarcinoma by E2F1 and STAT1
Transcription Factors
Courtney Schaal, Srikumar Chellappan, and Gokul M. Das
PLOS ONE
(2016)
11 :e0156451
-
Identification of candidate biomarkers and analysis of prognostic values in ovarian cancer by integrated bioinformatics analysis
Zhanzhan Xu, Yu Zhou, Yexuan Cao, Thi Lan Anh Dinh, Jing Wan, and Min Zhao
Medical Oncology
(2016)
33 :
-
Exploring functions of long noncoding RNAs across multiple cancers through co-expression network
Suqing Li, Bin Li, Yuanting Zheng, Menglong Li, Leming Shi, and Xuemei Pu
Scientific Reports
(2017)
7 :
-
Paradoxical Roles of Mineral Dust Induced Gene on Cell Proliferation and Migration/Invasion
Miaomiao Yu, Jiaying Sun, Chitra Thakur, Bailing Chen, Yongju Lu, Hongwen Zhao, Fei Chen, and Gutian Xiao
PLoS ONE
(2014)
9 :e87998
-
The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancer
Thomas G. Hopkins, Manuela Mura, Hiba A. Al-Ashtal, Roni M. Lahr, Normala Abd-Latip, Katrina Sweeney, Haonan Lu, Justin Weir,
Mona El-Bahrawy, Jennifer H. Steel, Sadaf Ghaem-Maghami, Eric O. Aboagye, Andrea J. Berman, and Sarah P. Blagden
Nucleic Acids Research
(2016)
44 :1227
-
hGBP-1 Expression Predicts Shorter Progression-Free Survival in Ovarian Cancers, While Contributing to Paclitaxel Resistance
Suzan Wadi, Aaron R. Tipton, Jill A. Trendel, Sadik A. Khuder, and Deborah J. Vestal
Journal of Cancer Therapy
(2016)
07 :994
-
Differential expression of argininosuccinate synthetase in serous and non-serous ovarian carcinomas
Dong-Joo Cheon, Ann E Walts, Jessica A Beach, Jenny Lester, John S Bomalaski, Christine S Walsh, W Ruprecht Wiedemeyer, Beth
Y Karlan, and Sandra Orsulic
The Journal of Pathology: Clinical Research
(2015)
1 :41
-
High IGF2 expression is associated with poor clinical outcome in human ovarian cancer
YAN DONG, JIANJUN LI, FEI HAN, HONGQIANG CHEN, XIAOXIN ZHAO, QIN QIN, RONGHUI SHI, and JINYI LIU
Oncology Reports
(2015)
34 :936
-
OPG and PgR show similar cohort specific effects as prognostic factors in ER positive breast cancer
Nicole Sänger, Eugen Ruckhäberle, Giampaolo Bianchini, Tomas Heinrich, Karin Milde-Langosch, Volkmar Müller, Achim Rody, Erich
Franz Solomayer, Tanja Fehm, Uwe Holtrich, Sven Becker, and Thomas Karn
Molecular Oncology
(2014)
8 :1196
-
Adenosine-generating ovarian cancer cells attract myeloid cells which differentiate into adenosine-generating tumor associated
macrophages – a self-amplifying, CD39- and CD73-dependent mechanism for tumor immune escape
Itsaso Montalbán del Barrio, Cornelia Penski, Laura Schlahsa, Roland G. Stein, Joachim Diessner, Achim Wöckel, Johannes Dietl,
Manfred B. Lutz, Michel Mittelbronn, Jörg Wischhusen, and Sebastian F. M. Häusler
Journal for ImmunoTherapy of Cancer
(2016)
4 :
-
SMARCE1 is required for the invasive progression of in situ cancers
Ethan S. Sokol, Yu-Xiong Feng, Dexter X. Jin, Minu D. Tizabi, Daniel H. Miller, Malkiel A. Cohen, Sandhya Sanduja, Ferenc
Reinhardt, Jai Pandey, Daphne A. Superville, Rudolf Jaenisch, and Piyush B. Gupta
Proceedings of the National Academy of Sciences
(2017)
114 :4153
-
Initiation of the ATM-Chk2 DNA damage response through the base excision repair pathway
Wen-Cheng Chou, Ling-Yueh Hu, Chia-Ni Hsiung, and Chen-Yang Shen
Carcinogenesis
(2015)
36 :832
-
Computational analyses reveal a prognostic impact of TULP3 as a transcriptional master regulator in pancreatic ductal adenocarcinoma
I. T. S. Sartor, F. Zeidán-Chuliá, R. D. Albanus, R. J. S. Dalmolin, and J. C. F. Moreira
Mol. BioSyst.
(2014)
10 :1461
-
Cell division cycle 20 overexpression predicts poor prognosis for patients with lung adenocarcinoma
Run Shi, Qi Sun, Jing Sun, Xin Wang, Wenjie Xia, Gaochao Dong, Anpeng Wang, Feng Jiang, and Lin Xu
Tumor Biology
(2017)
39 :101042831769223
-
Interferon signaling in ascites-associated macrophages is linked to a favorable clinical outcome in a subgroup of ovarian
carcinoma patients
Till Adhikary, Annika Wortmann, Florian Finkernagel, Sonja Lieber, Andrea Nist, Thorsten Stiewe, Uwe Wagner, Sabine Müller-Brüsselbach,
Silke Reinartz, and Rolf Müller
BMC Genomics
(2017)
18 :
-
An In Vivo Gain-of-Function Screen Identifies the Williams-Beuren Syndrome Gene GTF2IRD1 as a Mammary Tumor Promoter
Yongliang Huo, Timothy Su, Qiuyin Cai, and Ian G. Macara
Cell Reports
(2016)
15 :2089
-
Extracellular vesicles for personalized therapy decision support in advanced metastatic cancers and its potential impact for
prostate cancer
Carolina Soekmadji, Niall M. Corcoran, Irina Oleinikova, Lidija Jovanovic, Grant A. Ramm, Colleen C. Nelson, Guido Jenster,
and Pamela J. Russell
The Prostate
(2017)
77 :1416
-
High Expression of FGD3, a Putative Regulator of Cell Morphology and Motility, Is Prognostic of Favorable Outcome in Multiple
Cancers
Scooter Willis, Yuliang Sun, Mark Abramovitz, Teng Fei, Brandon Young, Xiaoqian Lin, Min Ni, Justin Achua, Meredith M. Regan,
Kathryn P. Gray, Robert Gray, Victoria Wang, Bradley Long, Roswitha Kammler, Joseph A. Sparano, Casey Williams, Lori J. Goldstein,
Roberto Salgado, Sherene Loi, Giancarlo Pruneri, Giuseppe Viale, Myles Brown, and Brian Leyland-Jones
JCO Precision Oncology
(2017)
:1
-
Spliceosome-associated factor CTNNBL1 promotes proliferation and invasion in ovarian cancer
Yingwei Li, Haiyang Guo, Chengjuan Jin, Chunping Qiu, Min Gao, Lei Zhang, Zhaojian Liu, and Beihua Kong
Experimental Cell Research
(2017)
357 :124
-
Distinct prognostic values of four-Notch-receptor mRNA expression in ovarian cancer
Xinling Zhou, Lingling Teng, and Min Wang
Tumor Biology
(2016)
37 :6979
-
LSD1 Overexpression Is Associated with Poor Prognosis in Basal-Like Breast Cancer, and Sensitivity to PARP Inhibition
Satoi Nagasawa, Anna S. Sedukhina, Yuko Nakagawa, Ichiro Maeda, Manabu Kubota, Shigeko Ohnuma, Koichiro Tsugawa, Tomohiko
Ohta, Marta Roche-Molina, Juan A. Bernal, Ana J. Narváez, Anand D. Jeyasekharan, Ko Sato, and Jindan Yu
PLOS ONE
(2015)
10 :e0118002
-
Survival analysis tools in genomics research
Xintong Chen, Xiaochen Sun, and Yujin Hoshida
Human Genomics
(2014)
8 :
-
Guanylate-Binding Protein-1 protects ovarian cancer cell lines but not breast cancer cell lines from killing by paclitaxel
Aaron R. Tipton, Geoffrey O. Nyabuto, Jill A. Trendel, Travis M. Mazur, John P. Wilson, Suzan Wadi, Jacob S. Justinger, Garret
L. Moore, Peter T. Nguyen, and Deborah J. Vestal
Biochemical and Biophysical Research Communications
(2016)
478 :1617
-
Long non-coding RNAs, ASAP1-IT1, FAM215A, and LINC00472, in epithelial ovarian cancer
Yuanyuan Fu, Nicoletta Biglia, Zhanwei Wang, Yi Shen, Harvey A. Risch, Lingeng Lu, Emilie Marion Canuto, Wei Jia, Dionyssios
Katsaros, and Herbert Yu
Gynecologic Oncology
(2016)
143 :642
-
The Splicing Factor RBM4 Controls Apoptosis, Proliferation, and Migration to Suppress Tumor Progression
Yang Wang, Dan Chen, Haili Qian, Yihsuan S. Tsai, Shujuan Shao, Quentin Liu, Daniel Dominguez, and Zefeng Wang
Cancer Cell
(2014)
26 :374
-
Ectodomain shedding of the cell adhesion molecule Nectin-4 in ovarian cancer is mediated by ADAM10 and ADAM17
Petra C. Buchanan, Kristin L. M. Boylan, Bruce Walcheck, Rachel Heinze, Melissa A. Geller, Peter A. Argenta, and Amy P. N.
Skubitz
Journal of Biological Chemistry
(2017)
292 :6339
-
PHLDA1 expression is controlled by an estrogen receptor-NFκB-miR-181 regulatory loop and is essential for formation of ER+
mammospheres
I Kastrati, E Canestrari, and J Frasor
Oncogene
(2015)
34 :2309
-
Prognostic values of Notch receptors in breast cancer
Junming Xu, Fangbin Song, Tao Jin, Jun Qin, Junyi Wu, Min Wang, Ye Wang, and Jun Liu
Tumor Biology
(2016)
37 :1871
-
Regulation of triple-negative breast cancer cell metastasis by the tumor-suppressor liver kinase B1
L V Rhodes, C R Tate, V T Hoang, H E Burks, D Gilliam, E C Martin, S Elliott, D B Miller, A Buechlein, D Rusch, H Tang, K
P Nephew, M E Burow, and B M Collins-Burow
Oncogenesis
(2015)
4 :e168
-
The sialyl-glycolipid stage-specific embryonic antigen 4 marks a subpopulation of chemotherapy-resistant breast cancer cells
with mesenchymal features
Andrea Aloia, Evgeniya Petrova, Stefan Tomiuk, Ute Bissels, Olivier Déas, Massimo Saini, Franziska Maria Zickgraf, Steve Wagner,
Saskia Spaich, Marc Sütterlin, Andreas Schneeweiss, Manuel Reitberger, Silvia Rüberg, Bernhard Gerstmayer, David Agorku, Sebastian
Knöbel, Annalisa Terranegra, Monica Falleni, Laura Soldati, Martin Ronald Sprick, Andreas Trumpp, Jean-Gabriel Judde, Andreas
Bosio, Stefano Cairo, and Olaf Hardt
Breast Cancer Research
(2015)
17 :
-
Reciprocal activation of α5-nAChR and STAT3 in nicotine-induced human lung cancer cell proliferation
Yao Zhang, Yanfei Jia, Ping Li, Huanjie li, Dongjie Xiao, Yunshan Wang, and Xiaoli Ma
Journal of Genetics and Genomics
(2017)
44 :355
-
Breast cancer cell adhesome and degradome interact to drive metastasis
Asif Rizwan, Menglin Cheng, Zaver M Bhujwalla, Balaji Krishnamachary, Lu Jiang, and Kristine Glunde
npj Breast Cancer
(2015)
1 :
-
Genome-wide methylation profiling of ovarian cancer patient-derived xenografts treated with the demethylating agent decitabine
identifies novel epigenetically regulated genes and pathways
Tushar Tomar, Steven de Jong, Nicolette G. Alkema, Rieks L. Hoekman, Gert Jan Meersma, Harry G. Klip, Ate GJ van der Zee,
and G. Bea A. Wisman
Genome Medicine
(2016)
8 :
-
Network-based stratification of tumor mutations
Matan Hofree, John P Shen, Hannah Carter, Andrew Gross, and Trey Ideker
Nature Methods
(2013)
10 :1108
-
Identification of novel cancer therapeutic targets using a designed and pooled shRNA library screen
David Oliver, Hao Ji, Piaomu Liu, Alexander Gasparian, Ellen Gardiner, Samuel Lee, Adrian Zenteno, Lillian O. Perinskaya,
Mengqian Chen, Phillip Buckhaults, Eugenia Broude, Michael D. Wyatt, Homayoun Valafar, Edsel Peña, and Michael Shtutman
Scientific Reports
(2017)
7 :43023
-
WOMEN IN CANCER THEMATIC REVIEW: Ovarian cancer–peritoneal cell interactions promote extracellular matrix processing
C Ricciardelli, N A Lokman, M P Ween, and M K Oehler
Endocrine-Related Cancer
(2016)
23 :T155
-
Annexin A2 and S100A10 are independent predictors of serous ovarian cancer outcome
Noor A. Lokman, Carmen E. Pyragius, Andrew Ruszkiewicz, Martin K. Oehler, and Carmela Ricciardelli
Translational Research
(2016)
171 :83
-
Mining CK2 in Cancer
Charina E. Ortega, Yoshua Seidner, Isabel Dominguez, and Raffaele A. Calogero
PLoS ONE
(2014)
9 :e115609
-
Meta-Analysis of Public Microarray Datasets Reveals Voltage-Gated Calcium Gene Signatures in Clinical Cancer Patients
Chih-Yang Wang, Ming-Derg Lai, Nam Nhut Phan, Zhengda Sun, Yen-Chang Lin, and Jörg D. Hoheisel
PLOS ONE
(2015)
10 :e0125766
-
Evaluation of the TRPM2 channel as a biomarker in breast cancer using public databases analysis
Adriana Sumoza-Toledo, Mario Iván Espinoza-Gabriel, and Dvorak Montiel-Condado
Boletín Médico del Hospital Infantil de México
(2016)
73 :397
-
Expression and prognostic value of E2F activators in NSCLC and subtypes: a research based on bioinformatics analysis
Zhaojia Gao, Run Shi, Kai Yuan, and Yong Wang
Tumor Biology
(2016)
37 :14979
-
The NER-related geneGTF2H5predicts survival in high-grade serous ovarian cancer patients
Javier Gayarre, Marta M. Kamieniak, Alicia Cazorla-Jiménez, Ivan Muñoz-Repeto, Salud Borrego, Jesús García-Donas, Susana Hernando,
Luis Robles-Díaz, José M. García-Bueno, Teresa Ramón y Cajal, Elena Hernández-Agudo, Victoria Heredia Soto, Ivan Márquez-Rodas,
María José Echarri, Carmen Lacambra-Calvet, Raquel Sáez, Maite Cusidó, Andrés Redondo, Luis Paz-Ares, David Hardisson, Marta
Mendiola, José Palacios, Javier Benítez, and María José García
Journal of Gynecologic Oncology
(2016)
27 :e7
-
The histone demethylase KDM4B regulates peritoneal seeding of ovarian cancer
C Wilson, L Qiu, Y Hong, T Karnik, G Tadros, B Mau, T Ma, Y Mu, J New, R J Louie, S Gunewardena, A K Godwin, O W Tawfik, J
Chien, K F Roby, and A J Krieg
Oncogene
(2017)
36 :2565
-
Single Gene Prognostic Biomarkers in Ovarian Cancer: A Meta-Analysis
Scooter Willis, Victor M. Villalobos, Olivier Gevaert, Mark Abramovitz, Casey Williams, Branimir I. Sikic, Brian Leyland-Jones,
and William B. Coleman
PLOS ONE
(2016)
11 :e0149183
-
Reverse Engineering the Neuroblastoma Regulatory Network Uncovers MAX as One of the Master Regulators of Tumor Progression
Ricardo D’Oliveira Albanus, Rodrigo Juliani Siqueira Dalmolin, Mauro Antônio Alves Castro, Matheus Augusto de Bittencourt
Pasquali, Vitor de Miranda Ramos, Daniel Pens Gelain, José Cláudio Fonseca Moreira, and Javier S Castresana
PLoS ONE
(2013)
8 :e82457
-
Protein Kinase CK2 Expression Predicts Relapse Survival in ERα Dependent Breast Cancer, and Modulates ERα Expression in Vitro
Marlon Williams, Thu Nguyen, Patrick Carriere, Syreeta Tilghman, and Christopher Williams
International Journal of Environmental Research and Public Health
(2015)
13 :36
-
WEE1 inhibition targets cell cycle checkpoints for triple negative breast cancers to overcome cisplatin resistance
Hongping Zheng, Fangyuan Shao, Scots Martin, Xiaoling Xu, and Chu-Xia Deng
Scientific Reports
(2017)
7 :43517
-
Membrane bile acid receptor TGR5 predicts good prognosis in ampullary adenocarcinoma patients with hyperbilirubinemia
Min-Chan Chen, Yi-Ling Chen, Tzu-Wen Wang, Hui-Ping Hsu, and Ming-Derg Lai
Oncology Reports
(2016)
36 :1997
-
Methylome analysis of extreme chemoresponsive patients identifies novel markers of platinum sensitivity in high-grade serous
ovarian cancer
Tushar Tomar, Nicolette G. Alkema, Leroy Schreuder, Gert Jan Meersma, Tim de Meyer, Wim van Criekinge, Harry G. Klip, Heidi
Fiegl, Els van Nieuwenhuysen, Ignace Vergote, Martin Widschwendter, Ed Schuuring, Ate G. J. van der Zee, Steven de Jong, and
G. Bea A. Wisman
BMC Medicine
(2017)
15 :
-
Establishing the Role of PPARβ/δ in Carcinogenesis
Jeffrey M. Peters, Frank J. Gonzalez, and Rolf Müller
Trends in Endocrinology & Metabolism
(2015)
26 :595
-
Immunological metagene signatures derived from immunogenic cancer cell death associate with improved survival of patients
with lung, breast or ovarian malignancies: A large-scale meta-analysis
Abhishek D. Garg, Dirk De Ruysscher, and Patrizia Agostinis
OncoImmunology
(2016)
5 :e1069938
-
Targeting of topoisomerases for prognosis and drug resistance in ovarian cancer
Yang Bai, Liang-Dong Li, Jun Li, and Xin Lu
Journal of Ovarian Research
(2016)
9 :
-
miR-339-5p inhibits migration and invasion in ovarian cancer cell lines by targeting NACC1 and BCL6
Weiwei Shan, Jun Li, Yang Bai, and Xin Lu
Tumor Biology
(2016)
37 :5203
-
Plasmin(ogen) serves as a favorable biomarker for prediction of survival in advanced high-grade serous ovarian cancer
Shuo Zhao, Julia Dorn, Rudolf Napieralski, Axel Walch, Sandra Diersch, Matthias Kotzsch, Nancy Ahmed, John D. Hooper, Marion
Kiechle, Manfred Schmitt, and Viktor Magdolen
Biological Chemistry
(2017)
398 :
-
hRAD9 functions as a tumor suppressor by inducing p21-dependent senescence and suppressing epithelial–mesenchymal transition
through inhibition of Slug transcription
Fan-Chih Wen, Tsai-Wang Chang, Yau-Lin Tseng, Janq-Chang Lee, and Ming-Chung Chang
Carcinogenesis
(2014)
35 :1481
-
STRIPAK components determine mode of cancer cell migration and metastasis
Chris D. Madsen, Steven Hooper, Melda Tozluoglu, Andreas Bruckbauer, Georgina Fletcher, Janine T. Erler, Paul A. Bates, Barry
Thompson, and Erik Sahai
Nature Cell Biology
(2014)
17 :68
-
Estrogen receptor-α directly regulates the hypoxia-inducible factor 1 pathway associated with antiestrogen response in breast
cancer
Jun Yang, Alaa AlTahan, Dylan T. Jones, Francesca M. Buffa, Esther Bridges, Rodrigo B. Interiano, Chunxu Qu, Nathan Vogt,
Ji-Liang Li, Dilair Baban, Jiannis Ragoussis, Robert Nicholson, Andrew M. Davidoff, and Adrian L. Harris
Proceedings of the National Academy of Sciences
(2015)
112 :15172
-
Endogenous tRNA-Derived Fragments Suppress Breast Cancer Progression via YBX1 Displacement
Hani Goodarzi, Xuhang Liu, Hoang C.B. Nguyen, Steven Zhang, Lisa Fish, and Sohail F. Tavazoie
Cell
(2015)
161 :790
-
PPISURV: a novel bioinformatics tool for uncovering the hidden role of specific genes in cancer survival outcome
A V Antonov, M Krestyaninova, R A Knight, I Rodchenkov, G Melino, and N A Barlev
Oncogene
(2014)
33 :1621
-
The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERα
Adrian Britschgi, Stephan Duss, Sungeun Kim, Joana Pinto Couto, Heike Brinkhaus, Shany Koren, Duvini De Silva, Kirsten D.
Mertz, Daniela Kaup, Zsuzsanna Varga, Hans Voshol, Alexandra Vissieres, Cedric Leroy, Tim Roloff, Michael B. Stadler, Christina
H. Scheel, Loren J. Miraglia, Anthony P. Orth, Ghislain M. C. Bonamy, Venkateshwar A. Reddy, and Mohamed Bentires-Alj
Nature
(2017)
541 :541
-
Adrenergic-mediated increases in INHBA drive CAF phenotype and collagens
Archana S. Nagaraja, Robert L. Dood, Guillermo Armaiz-Pena, Yu Kang, Sherry Y. Wu, Julie K. Allen, Nicholas B. Jennings, Lingegowda
S. Mangala, Sunila Pradeep, Yasmin Lyons, Monika Haemmerle, Kshipra M. Gharpure, Nouara C. Sadaoui, Cristian Rodriguez-Aguayo,
Cristina Ivan, Ying Wang, Keith Baggerly, Prahlad Ram, Gabriel Lopez-Berestein, Jinsong Liu, Samuel C. Mok, Lorenzo Cohen,
Susan K. Lutgendorf, Steve W. Cole, and Anil K. Sood
JCI Insight
(2017)
2 :
-
Synthetic dosage lethality in the human metabolic network is highly predictive of tumor growth and cancer patient survival
Wout Megchelenbrink, Rotem Katzir, Xiaowen Lu, Eytan Ruppin, and Richard A. Notebaart
Proceedings of the National Academy of Sciences
(2015)
112 :12217
-
FZD2 inhibits the cell growth and migration of salivary adenoid cystic carcinomas
LIN-CAN DING, XIAO-YU HUANG, FEI-FEI ZHENG, JIAN XIE, LIN SHE, YAN FENG, BO-HUA SU, DA-LI ZHENG, and YOU-GUANG LU
Oncology Reports
(2016)
35 :1006
-
Improving Pathological Assessment of Breast Cancer by Employing Array-Based Transcriptome Analysis
Zsuzsanna Mihály and Balázs Győrffy
Microarrays
(2013)
2 :228
-
Clinical utility of kallikrein-related peptidases (KLK) in urogenital malignancies
J. Dorn, J. Bayani, G. M. Yousef, F. Yang, V. Magdolen, M. Kiechle, E. P. Diamandis, and M. Schmitt
Thrombosis and Haemostasis
(2013)
110 :408
-
VCP inhibitors induce endoplasmic reticulum stress, cause cell cycle arrest, trigger caspase-mediated cell death and synergistically
kill ovarian cancer cells in combination with Salubrinal
Prabhakar Bastola, Lisa Neums, Frank J. Schoenen, and Jeremy Chien
Molecular Oncology
(2016)
10 :1559
